However, the expression, methylation, and the prognosis of CCT6A in NSCLC LUAD subtype remain largely unknown, and the associations between EGFR, CCT6A, and CHCHD2 at expression levels are still unclear in LUAD. This evidence concerns the gene EGFR and non-small cell lung carcinoma.